T-Cell Lymphomas Global Clinical Trials Review, H1, 2014

Date: May 21, 2014
Pages: 104
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T85D16FB2A9EN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H1, 2014' provides data on the T-Cell Lymphomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on T-Cell Lymphomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating T-Cell Lymphomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
T-Cell Lymphomas
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of T-Cell Lymphomas to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of T-Cell Lymphomas
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in T-Cell Lymphomas Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on T-Cell Lymphomas
Dec 06, 2013: Rhizen Pharmaceuticals announces initiation of a “First in Human” Phase-1 trial of RP6530, a dual PI3K delta/gamma inhibitor, in patients with hematological malignancies
Jan 24, 2013: Seattle Genetics And Millennium Initiate Global Phase III Clinical Trial Of Adcetris In Front-line CD30-Expressing Mature T-Cell Lymphoma
Dec 10, 2012: Infinity Pharma Reports IPI-145 Phase I Data Showing Clinical Activity In B-Cell And T-Cell Malignancies At ASH Annual Meeting
Dec 09, 2012: Millennium And Takeda Report Data From Phase I Trial Of Adcetris In Front-line Mature T-Cell Lymphomas
May 07, 2012: Millennium And Seattle Initiate Phase III Trial Of ADCETRIS In Patients With CD30-Expressing Relapsed Cutaneous T-cell Lymphoma
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Spectrum Pharmaceuticals, Inc.
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Kirin Holdings Company, Limited
Clinical Trial Overview of Kirin Holdings Company, Limited
Bayer AG
Clinical Trial Overview of Bayer AG
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
Sun Yat-sen University
Clinical Trial Overview of Sun Yat-sen University
FUDAN University
Clinical Trial Overview of FUDAN University
University of Nebraska
Clinical Trial Overview of University of Nebraska
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
University of Washington
Clinical Trial Overview of University of Washington
Children's Oncology Group
Clinical Trial Overview of Children's Oncology Group
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014*
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014*
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
T-Cell Lymphomas Therapeutics, Global, Suspended Clinical Trials, 2014*
T-Cell Lymphomas Therapeutics, Global, Withdrawn Clinical Trials, 2014*
T-Cell Lymphomas Therapeutics, Global, Terminated Clinical Trials, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*

LIST OF FIGURES

T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Region (%), 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, G7 Countries (%), 2014*
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
T-Cell Lymphomas Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of T-Cell Lymphomas to Oncology Clinical Trials, E7 Countries (%), 2014*
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
T-Cell Lymphomas Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Phase (%), 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
T-Cell Lymphomas Therapeutics, Global, Clinical Trials by Trial Status, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, by End Point Status, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
T-Cell Lymphomas Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
T-Cell Lymphomas Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
GlobalData Methodology
Skip to top


Ask Your Question

T-Cell Lymphomas Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: